Acquired Resistance to PD-1/PD-L1 Blockade in Lung Cancer: Mechanisms and Patterns of Failure

Acquired Resistance to PD-1/PD-L1 Blockade in Lung Cancer: Mechanisms and Patterns of Failure

Immunotherapy is now the preferred treatment for most lung cancer patients. It is used to treat unresectable stage III non-small-cell lung cancer and is the first-line therapy for non-oncogene-driven advanced/metastatic non-small-cell lung cancer patients (either alone or in combination with chemoth...

Full description

Bibliographic Details
Main Authors: Ranjan Pathak, Rebecca R. Pharaon, Atish Mohanty, Victoria M. Villaflor, Ravi Salgia, Erminia Massarelli
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Cancers
Subjects:
lung cancer
PD-1
PD-L1
immunotherapy
immune checkpoint inhibitors
acquired resistance
Online Access:https://www.mdpi.com/2072-6694/12/12/3851

Internet

https://www.mdpi.com/2072-6694/12/12/3851

Similar Items